⌘K

Login Start Free

Home/Filings/4/0000940805-25-000004

4//SEC Filing

SCHWARTZ NORMAN D 4

Accession 0000940805-25-000004

CIK 0000012208other

View on SEC.gov Company Profile

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 6:00 PM ET

Size

15.5 KB

Accession

0000940805-25-000004

Insider Transaction Report

Form 4

Period: 2025-09-01

BIO-RAD LABORATORIES, INC.BIO BIO.B

SCHWARTZ NORMAN D

DirectorCEO10% Owner

Transactions

Exercise/Conversion
Bio-Rad A Common Stock
2025-09-01+6,353→ 444,591 total
Exercise/Conversion
Restricted Stock Units
2025-09-01−1,266→ 0 total
Exercise: $0.00→ Bio-Rad A Common Stock (1,266 underlying)
Tax Payment
Bio-Rad A Common Stock
2025-09-01$297.88/sh−3,084$918,662→ 441,507 total
Exercise/Conversion
Restricted Stock Units
2025-09-01−2,082→ 2,082 total
Exercise: $0.00→ Bio-Rad A Common Stock (2,082 underlying)
Exercise/Conversion
Restricted Stock Units
2025-09-01−3,005→ 6,010 total
Exercise: $0.00→ Bio-Rad A Common Stock (3,005 underlying)

Holdings

Bio-Rad B Common Stock
(indirect: By Spouse)
13,006
Bio-Rad B Common Stock
361,466
Bio-Rad B Common Stock
(indirect: By Blue Raven Partners, L.P.)
4,060,054

Footnotes (7)

[F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
[F2]The reporting person disclaims beneficial ownership of these shares.
[F3]The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
[F4]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
[F5]On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F6]On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F7]On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file

4
wk-form4_1756936850.xmlPrimary
FORM 4

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

Entity typeother

Related Parties

1

filerCIK 0000940805

Filing Metadata

Form type: 4
Filed: Sep 2, 8:00 PM ET
Accepted: Sep 3, 6:00 PM ET
Size: 15.5 KB

View on SEC.gov